Thermo Fisher Unveils Automated Cell Therapy Fill and Finish System

New Gibco CTS Compleo system aims to streamline manufacturing and reduce variability.

Apr. 2, 2026 at 5:14pm

Thermo Fisher Scientific, a global leader in scientific instrumentation and life sciences, has introduced the Gibco CTS Compleo Fill and Finish System to help address a key bottleneck in cell therapy manufacturing - the manual fill and finish process. The new automated, functionally closed system is designed to support more reliable and consistent outcomes in cell therapy production.

Why it matters

Cell therapy is a rapidly growing field, but manual fill and finish steps have been a persistent challenge, introducing variability and limiting scalability. Thermo Fisher's new Gibco CTS Compleo system aims to help cell therapy manufacturers improve efficiency, consistency, and quality control in this critical stage of the production process.

The details

The Gibco CTS Compleo Fill and Finish System provides an automated, functionally closed approach to the fill and finish steps of cell therapy manufacturing. This helps address variability and supports more reliable, consistent outcomes compared to manual processes. The system is designed to integrate seamlessly with existing workflows to streamline cell therapy production.

  • Thermo Fisher Scientific introduced the new Gibco CTS Compleo system on April 2, 2026.

The players

Thermo Fisher Scientific

A global leader in scientific instrumentation, equipment, and life sciences products, serving customers in pharmaceutical, biotechnology, academic, government, and other markets.

Got photos? Submit your photos here. ›

The takeaway

Thermo Fisher's new Gibco CTS Compleo system represents an important step forward in streamlining cell therapy manufacturing, addressing a key pain point around manual fill and finish processes. This automated, functionally closed solution has the potential to improve consistency, quality, and scalability for cell therapy producers.